A Pilot Newborn Screening for Congenital Adrenal Hyperplasia in Alaska*
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A pilot newborn screening program for 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH) was conducted in Alaska using a 3-mm disc filter paper elution technique of capillary whole blood for 17-hydroxyprogesterone (17-OHP) by RIA. The filter paper specimens were provided via the mandated newborn screening program. The highest values of 17-OHP in a control population of 4569 consecutive normal neonates, aged 2–14 days, was 40 pg/disc, and the range of values for 20 newborns with proven CAH was 57–980 pg/disc. All Alaskan newborns with 17-OHP levels of 57 pg/disc or greater were referred for diagnostic workup, and initially, those with 17-OHP levels of 41–56 pg/disc were recalled for a second specimen. However, the range for recall was changed subsequently to the 17-OHP level greater than 51 pg/disc, since no newborns with 17-OHP level below 50 pg/disc were found to be affected in the initial screening. In a 30-month period, the Alaskan newborns screened on the third day of life consisted of a total of 19,677 consecutive births (13,733 Caucasians, 1,131 Yupik Eskimos, 3,173 other natives, and 1,640 others). Sixteen had 17-OHP values greater than 57 pg/disc, of which 4 (3 Yupik Eskimos and 1 Caucasian) were proven to have the salt-losing form of CAH. Of the remaining 12, 4 were not available for follow-up; 8 were distressed premature infants, including 2 infants who died with severe prematurity. In addition, 1 Yupik Eskimo newborn who was clinically suspected and treated for CAH at birth before confirmation of the diagnosis, was subsequently confirmed to have CAH by filter paper 17-OHP determination off treatment. Of the 14 newborns whose 17-OHP values were 51–56 pg/disc, 13 were recalled and proven to be normal, and 1 could not be located. Thus, the neonatal Alaskan screening, including 1 newborn who was clinically suspected for CAH, revealed 4 infants with the salt-losing form of CAH in 1,131 live births in Yupik Eskimos and 1 infant with the salt-losing form of CAH in 13,733 Caucasian live births. These data indicate a prevalence of this disorder of 1 in 282 in Yupik Eskimo live births and 1 in 13,733 in Caucasian live births. The false positive and recall rates were 0.05% and 0.1%, respectively. The present study demonstrates the feasibility of a newborn screening program for CAH and indicates that the frequency of the salt-losing form of CAH may be greater than previously reported by the case assessment method in Yupik Eskimos in Alaska.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Self-citation
Cited by
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
How sexually dimorphic are we? Review and synthesis
Blackless, M., Charuvastra, A., Derryck, A., Fausto-Sterling, A., Lauzanne, K., & Lee, E. (2000) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(200003/04)12:2<151::aid-ajhb1>3.0.co;2-f · Cited by 857
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Metadata
- Authors
- PANG, S., MURPHEY, W., LEVINE, L. S., SPENCE, D. A., LEON, A., LAFRANCHI, S., SURVE, A. S., & NEW, M. I.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1982-09
- Volume
- 55
- Issue
- 3
- Pages
- 413-420
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2115832156
- Cited by
- 157
- References
- 1
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.